{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T02:26:52Z","timestamp":1777861612882,"version":"3.51.4"},"reference-count":25,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["R03 AR065014"],"award-info":[{"award-number":["R03 AR065014"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["K24AR069760"],"award-info":[{"award-number":["K24AR069760"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["R03AR064014"],"award-info":[{"award-number":["R03AR064014"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.jaad.2018.11.024","type":"journal-article","created":{"date-parts":[[2018,11,17]],"date-time":"2018-11-17T11:35:12Z","timestamp":1542454512000},"page":"998-1005","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Comparative effectiveness of treatment of actinic keratosis with topical fluorouracil and imiquimod in the prevention of keratinocyte carcinoma: A\u00a0cohort study"],"prefix":"10.1016","volume":"80","author":[{"given":"Romain","family":"Neugebauer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine A.","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Sokil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary-Margaret","family":"Chren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary D.","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam M.","family":"Asgari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1 Pt 2","key":"10.1016\/j.jaad.2018.11.024_bib1","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1067\/mjd.2000.103342","article-title":"Epidemiology of actinic keratoses and squamous cell carcinoma","volume":"42","author":"Salasche","year":"2000","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"10.1016\/j.jaad.2018.11.024_bib2","first-page":"1045","article-title":"Frequency and cost of actinic keratosis treatment","volume":"32","author":"Warino","year":"2006","journal-title":"Dermatol Surg"},{"issue":"3","key":"10.1016\/j.jaad.2018.11.024_bib3","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.jaad.2006.05.048","article-title":"The burden of skin diseases: 2004 a joint project of the American Academy of Dermatology Association and the Society for Investigative Dermatology","volume":"55","author":"Bickers","year":"2006","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"10.1016\/j.jaad.2018.11.024_bib4","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1001\/archinte.158.7.726","article-title":"Most common dermatologic problems identified by internists, 1990-1994","volume":"158","author":"Feldman","year":"1998","journal-title":"Arch Intern Med"},{"issue":"2 Suppl","key":"10.1016\/j.jaad.2018.11.024_bib5","first-page":"8","article-title":"A survey of office visits for actinic keratosis as reported by NAMCS, 1990-1999. National Ambulatory Medical Care Survey","volume":"70","author":"Gupta","year":"2002","journal-title":"Cutis"},{"issue":"11","key":"10.1016\/j.jaad.2018.11.024_bib6","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1002\/cncr.24284","article-title":"Actinic keratoses: natural history and risk of malignant transformation in the Veterans Affairs Topical Tretinoin Chemoprevention Trial","volume":"115","author":"Criscione","year":"2009","journal-title":"Cancer"},{"issue":"1 Pt 2","key":"10.1016\/j.jaad.2018.11.024_bib7","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1067\/mjd.2000.103339","article-title":"The risk of progression to invasive disease","volume":"42","author":"Glogau","year":"2000","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl 66","key":"10.1016\/j.jaad.2018.11.024_bib8","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1046\/j.0366-077X.2003.05621.x","article-title":"Actinic keratosis: epidemiology and progression to squamous cell carcinoma","volume":"149","author":"Lebwohl","year":"2003","journal-title":"Br J Dermatol"},{"issue":"8589","key":"10.1016\/j.jaad.2018.11.024_bib9","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0140-6736(88)91658-3","article-title":"Malignant transformation of solar keratoses to squamous cell carcinoma","volume":"1","author":"Marks","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2018.11.024_bib10","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/bjd.14852","article-title":"Current perspective on actinic keratosis: a review","volume":"177","author":"Siegel","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2018.11.024_bib11","first-page":"CD004415","article-title":"Interventions for actinic keratoses","volume":"12","author":"Gupta","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.jaad.2018.11.024_bib12","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1001\/jamadermatol.2017.3631","article-title":"Chemoprevention of basal and squamous cell carcinoma with a single course of fluorouracil, 5%, cream: a randomized clinical trial","volume":"154","author":"Weinstock","year":"2018","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaad.2018.11.024_bib13","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.jaad.2017.12.042","article-title":"A real-world, community-based cohort study comparing the effectiveness of topical fluoruracil vs. topical imiquimod for the treatment of actinic keratoses","volume":"78","author":"Neugebauer","year":"2018","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2018.11.024_bib14","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1046\/j.1523-1747.2003.12350.x","article-title":"The increased risk of skin cancer is persistent after discontinuation of psoralen+ultraviolet A: a cohort study","volume":"121","author":"Nijsten","year":"2003","journal-title":"J Invest Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2018.11.024_bib15","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1093\/jnci\/djs529","article-title":"HIV infection status, immunodeficiency, and the incidence of non-melanoma skin cancer","volume":"105","author":"Silverberg","year":"2013","journal-title":"J Natl Cancer Inst"},{"issue":"11","key":"10.1016\/j.jaad.2018.11.024_bib16","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1038\/bjc.1996.642","article-title":"Non-Hodgkin's lymphomas, chronic lymphocytic leukaemias and skin cancers","volume":"74","author":"Levi","year":"1996","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1016\/j.jaad.2018.11.024_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1067\/mjd.2002.125579","article-title":"Skin cancer in organ transplant recipients: epidemiology, pathogenesis, and management","volume":"47","author":"Berg","year":"2002","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"10.1016\/j.jaad.2018.11.024_bib18","doi-asserted-by":"crossref","first-page":"738","DOI":"10.7326\/0003-4819-131-10-199911160-00004","article-title":"Malignant neoplasms in long-term survivors of bone marrow transplantation. Late Effects Working Party of the European Cooperative Group for Blood and Marrow Transplantation and the European Late Effect Project Group","volume":"131","author":"Kolb","year":"1999","journal-title":"Ann Intern Med"},{"issue":"8","key":"10.1016\/j.jaad.2018.11.024_bib19","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1038\/jid.2013.33","article-title":"Photosensitizing agents and the risk of non-melanoma skin cancer: a population-based case-control study","volume":"133","author":"Robinson","year":"2013","journal-title":"J Invest Dermatol"},{"issue":"7","key":"10.1016\/j.jaad.2018.11.024_bib20","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1136\/jech.2004.029496","article-title":"Estimating causal effects from epidemiological data","volume":"60","author":"Hern\u00e1n","year":"2006","journal-title":"J Epidemiol Community Health"},{"issue":"Suppl 2","key":"10.1016\/j.jaad.2018.11.024_bib21","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1365-2133.2007.08271.x","article-title":"A randomised study of topical 5% imiquimod vs. topical 5-fluorouracil vs. cryosurgery in immunocompetent patients with actinic keratoses: a comparison of clinical and histological outcomes including 1-year follow-up","volume":"157","author":"Krawtchenko","year":"2007","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2018.11.024_bib22","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1093\/aje\/kwn164","article-title":"Constructing inverse probability weights for marginal structural models","volume":"168","author":"Cole","year":"2008","journal-title":"Am J Epidemiol"},{"issue":"5","key":"10.1016\/j.jaad.2018.11.024_bib23","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/00001648-200009000-00011","article-title":"Marginal structural models and causal inference in epidemiology","volume":"11","author":"Robins","year":"2000","journal-title":"Epidemiology"},{"issue":"2","key":"10.1016\/j.jaad.2018.11.024_bib24","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/bjd.12343","article-title":"Network meta-analysis of the outcome \u201cparticipant complete clearance\u201d in nonimmunosuppressed participants of eight interventions for actinic keratosis: a follow-up on a Cochrane review","volume":"169","author":"Gupta","year":"2013","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2018.11.024_bib25","first-page":"144","article-title":"Comparison of 5% 5-fluorouracil cream and 5% imiquimod cream in the management of actinic keratoses on the face and scalp","volume":"6","author":"Tanghetti","year":"2007","journal-title":"J Drugs Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962218329141?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962218329141?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T04:35:36Z","timestamp":1777523736000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962218329141"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S0190962218329141"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2018.11.024","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative effectiveness of treatment of actinic keratosis with topical fluorouracil and imiquimod in the prevention of keratinocyte carcinoma: A\u00a0cohort study","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2018.11.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}